DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Efficacy of Darifenacin and Physiotherapy for the Treatment of Overactive Bladder in Women

Information source: Universidad de Valparaiso
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Overactive Bladder

Intervention: Darifenacin (Drug); Physiotherapy (Procedure)

Phase: Phase 3

Status: Recruiting

Sponsored by: Universidad de Valparaiso

Official(s) and/or principal investigator(s):
Melissa Cifuentes, M.D., Principal Investigator, Affiliation: Senior Urologist

Overall contact:
Melissa Cifuentes, M.D., Phone: 85023219, Ext: +56 9, Email: melissacifuentes@yahoo.com

Summary

Overactive bladder is a common problem among adult women. Darifenacin is an antimuscarinic drug that is frequently used as part of the management of the condition. However, current evidence backing its use is limited. This study aims to address Darifenacin's effectiveness in adjunct to physiotherapy in treating symptoms due to overactive bladder.

Clinical Details

Official title: Efficacy of Darifenacin and Physiotherapy for the Treatment of Overactive Bladder in Women

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Primary outcome: Quality of Life

Secondary outcome:

Overactive Bladder Symptoms

Adverse Events

Eligibility

Minimum age: 16 Years. Maximum age: N/A. Gender(s): Female.

Criteria:

Inclusion Criteria:

- Patients with overactive bladder as diagnosed and confirmed by a urologist.

- Able to answer the ICIC, King's Health Questionnaire and Overactive Bladder

Questionnaire.

- Able and willing to receive urodynamic studies.

Exclusion Criteria:

- History of pelvic radiotherapy.

- Recent pelvic surgery (<1 year).

- History of anti-incontinence surgery.

- Pregnancy.

Locations and Contacts

Melissa Cifuentes, M.D., Phone: 85023219, Ext: +56 9, Email: melissacifuentes@yahoo.com

Hospital Carlos Van Buren, Valparaiso 2341131, Chile; Recruiting
Juan Pablo Loyola, M.D., Phone: 89322457, Ext: +56 9, Email: juanpablo.loyola.m@gmail.com
Juan Pablo Loyola, M.D., Sub-Investigator
Melissa Cifuentes, M.D., Principal Investigator
Luis Vallejo, M.D., Principal Investigator
Karin Jerez, Physiotherapist, Sub-Investigator
Felipe Martinez, M.D; M.Sc., Sub-Investigator
Additional Information

Starting date: May 2014
Last updated: May 19, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017